The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome
Open accessAbstract
It is not understood how immune inflammation influences the pathogenesis of severe acute respiratory syndrome (SARS). One area of strong controversy is the role of interferon (IFN) responses in the natural history of SARS. The fact that the majority of SARS patients recover after relatively moderate illness suggests that the prevailing notion of deficient type I IFN-mediated immunity, with hypercytokinemia driving a poor clinical course, is oversimplified. We used proteomic and genomic technology to systematically analyze host innate and adaptive immune responses of 40 clinically well-described patients with SARS during discrete phases of illness from the onset of symptoms to discharge or a fatal outcome. A novel signature of high IFN-α, IFN-γ, and IFN-stimulated chemokine levels, plus robust antiviral IFN-stimulated gene (ISG) expression, accompanied early SARS sequelae. As acute illness progressed, SARS patients entered a crisis phase linked to oxygen saturation profiles. The majority of SARS patients resolved IFN responses at crisis and expressed adaptive immune genes. In contrast, patients with poor outcomes showed deviated ISG and immunoglobulin gene expression levels, persistent chemokine levels, and deficient anti-SARS spike antibody production. We contend that unregulated IFN responses during acute-phase SARS may culminate in a malfunction of the switch from innate immunity to adaptive immunity. The potential for the use of the gene signatures we describe in this study to better assess the immunopathology and clinical management of severe viral infections, such as SARS and avian influenza (H5N1), is therefore worth careful examination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Atypical IFNmediated immune responses suggest that type I IFN signaling may be important in the pathogenesis of SARS-CoV (21).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [21]
In the citing paper
“Gene expression signatures for type I and type II IFN responses in the lungs of SARS patients revealed persistent expression of CXCL10, CCL2, IFNAR1, IFNGR1, and CD58.”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [21]
Citations
Cites
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
Wong, C. K., LAM, C. W. K., Wu, A. K. L., Ip, W., Lee, N. L. S., Chan, I., Lit, L. C. W., Hui, D. S. C., Chan, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,270
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–392 of 392
Susilowati, I. H., Nakatani, H., Nugraha, S., Pengpid, S., Keawpan, W., Hasiholan, B. P., Toai, N. P., Abdeali, A., Isahak, M., & Kamso, S. (2020) · Global Health & Medicine · doi:10.35772/ghm.2020.01061 · Cited by 7
Inhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective
Cojocaru, E., Cojocaru, C., Antoniu, S. A., Stafie, C. S., Râjnoveanu, A. G., & Râjnoveanu, R. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2008910 · Cited by 7
Severe acute respiratory syndrome (SARS)
Beltz, L. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98809-4.00004-8 · Cited by 7
In silico pathway analysis: the final frontier towards completely rational drug design
Yuryev, A. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.8.867 · Cited by 7
Deng, Z., Liu, F., Ye, S., Zhu, X., He, X., Wang, S., Li, Y., Jiang, L., Wang, J., Lin, Y., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-54135/v1 · Cited by 7
Coronavirus: Pure Infectious Disease or Genetic Predisposition
Darbeheshti, F., Abolhassani, H., Bashashati, M., Ghavami, S., Shahkarami, S., Zoghi, S., Gupta, S., Orange, J. S., Ochs, H. D., & Rezaei, N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63761-3_6 · Cited by 6
Molecular Function of cGAS‐STING in SARS‐CoV‐2: A Novel Approach to COVID‐19 Treatment
Moossavi, M., Rastegar, M., Moossavi, S. Z., & Khorasani, M. (2022) · BioMed Research International · doi:10.1155/2022/6189254 · Cited by 6
Ferret TNF-α and IFN-γ Immunoassays
Ann, A., Banner, D., Danesh, A., Seneviratne, C., Ochi, A., & Joseph, D. (2012) · InTech eBooks · doi:10.5772/37193 · Cited by 5
Self-citationEvolving Landscape of Antibody Drug Conjugates in Lymphoma
Prakash, R., Subbiah, V., & Iyer, S. P. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000631 · Cited by 5
Inflammatory pathways and potential therapies for COVID-19: A mini review
Dabbish, A. M., Yonis, N., Salama, M., Essa, M. M., & Qoronfleh, M. W. (2021) · European Journal of Inflammation · doi:10.1177/20587392211002986 · Cited by 5
Gupta, A. K., & Chun, H. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693085 · Cited by 6
Papathanasiou, G. S. (2020) · Clinical Research Open Access · doi:10.16966/2469-6714.156 · Cited by 5
Onifade, A. A., & Arinola, G. O. (2020) · Saudi Journal of Biomedical Research · doi:10.36348/sjbr.2020.v05i11.006 · Cited by 5
Molecular mechanisms and signaling pathways involved in immunopathological events of COVID-19
Peyvandi, A. A., Niknazar, S., Mehrjerdi, F. Z., Abbaszadeh, H., Khoshsirat, S., & Peyvandi, M. (2021) · Physiology and Pharmacology · doi:10.52547/ppj.25.3.193 · Cited by 5
Green, D. S., Lum, T., Mullins, B., & Green, J. A. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21232 · Cited by 5
Screening gene signatures for clinical response subtypes of lung transplantation
Zhang, Y.-H., Li, Z.-D., Zeng, T., Chen, L., Huang, T., & Cai, Y.-P. (2022) · Zeitschrift für Induktive Abstammungs- und Vererbungslehre · doi:10.1007/s00438-022-01918-x · Cited by 4
Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients
Doğan, H., Kara, A., Çankaya, E., Balkan, E., Gürbüz, M. A., Kızılkaya, M., & Aykaç, M. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45020062 · Cited by 4
A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host
Minakshi, R., Jan, A. T., Rahman, S., & Kim, J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.575404 · Cited by 4
Anti-interferon armamentarium of human coronaviruses
Khatun, O., Kaur, S., & Tripathi, S. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05605-z · Cited by 3
Proposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors
Reddy, K. R., Faridi, K. F., Aggarwal, M., Tirumalai, A. A., Singh, T. K., Tejtel, S. K. S., Williams, K. A., Sr., Litwin, S. E., Dastmalchi, L. N., White, B. A., et al. (2024) · American Journal of Lifestyle Medicine · doi:10.1177/15598276241269532 · Cited by 3
Potential Roles of Vitamins in the Management of COVID-19: A Comprehensive Review
Rezaei, H., Khiali, S., Rezaee, H., Baghi, H. B., Pourghasem, M., & Entezari‐Maleki, T. (2021) · Pharmaceutical Sciences · doi:10.34172/ps.2021.41 · Cited by 3
SARS Coronavirus Pathogenesis and Therapeutic Treatment Design
Sheahan, T. P., & Baric, R. S. (2009) · Springer eBooks · doi:10.1007/978-3-642-03683-5_13 · Cited by 4
Participantes de la respuesta inmunológica ante la infección por SARS-CoV-2
Pérez, G. T. L., Sandoval, M. D. L. P. R., & Altamirano, M. S. T. (2020) · Alergia, Asma e Inmunología Pediátricas · doi:10.35366/93321 · Cited by 3
Gupta, S., & Gupta, S. (2020) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2020.03.0696 · Cited by 3
SARS-CoV-2 codon usage bias downregulates host expressed genes with similar codon usagePreprint
Alonso, A. M., & Diambra, L. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.05.079087 · Cited by 3
Jacob, R. A., Ajoge, H. O., D’Agostino, M. R., Shigayeva, A., Banerjee, A., Miller, M. S., McGeer, A., Mubareka, S., & Mossman, K. L. (2025) · npj Viruses · doi:10.1038/s44298-025-00149-2 · Cited by 3
Self-citationAbolghasemi, H., Kheiri, H., Sedighian, H., Behzadi, E., Kachuei, R., Kheirandish, M., Arabfard, M., & Fooladi, A. A. I. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2025.100650 · Cited by 2
A Game of Infection – Song of Respiratory Viruses and Interferons
Wang, G., Gu, Y., Wang, C., Wang, F., & Hsu, A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.937460 · Cited by 2
Coronaviruses and Arteriviruses
Narayanan, K., & Makino, S. (2014) · ASM Press eBooks · doi:10.1128/9781555815561.ch23 · Cited by 2
Samanta, R. J., Dunning, J. W., Taylor, A., Bayliffe, A. I., Chambers, R. C., Chilvers, E. R., Openshaw, P., & Summers, C. (2020) · medRxiv · doi:10.1101/2020.07.12.20150474 · Cited by 2
Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across SpeciesPreprint
Schäfer, A., Gralinski, L. E., Leist, S. R., Winkler, E. S., Hampton, B. K., Mooney, M. A., Jensen, K., Graham, R. L., Agnihothram, S., Jeng, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.14.444205 · Cited by 2
Vaccine-induced immune responses against SARS-CoV-2 infections
Garg, M. K., Maralakunte, M., Kumar, Y., Bhujade, H., Sehgal, I. P., Suri, V., & Garg, S. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00024 · Cited by 1
Mechanisms of pulmonary hypertension development in COVID-19
Tsareva, N. A. (2023) · PULMONOLOGIYA · doi:10.18093/0869-0189-2023-33-4-525-532 · Cited by 1
Mishra, K. A., Podili, R., Pathlavath, T. S., & Sethi, K. K. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23409 · Cited by 1
Pustake, M. V., Giri, P., Ganiyani, M. A., Mumtaz, K., Deshmukh, K., Saju, M. S. R., Nunez, J. V., Nv, O., & Das, A. (2023) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_460_22 · Cited by 1
Chen, C.-C., Lin, Y.-A., Liu, K., Huang, C., Shih, C., Lee, Y.-T., Pan, J.-L., & Lee, A.-W. (2024) · Virology Journal · doi:10.1186/s12985-024-02529-1 · Cited by 1
Age Matters: Key Contributors to Interferon Toxicity in Infants During Influenza Virus Infection
Onufer, A. P., & Carey, A. J. (2025) · Viruses · doi:10.3390/v17071002 · Cited by 1
Elshamaa, M. F. (2020) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/130368 · Cited by 1
Primer on the Pathogenesis of Severe COVID-19: Part One
Walsh, T. (2020) · European Medical Journal · doi:10.33590/emj/20-00158 · Cited by 1
Features of SARS-COV-2 infection and directions of drug and vaccine creation
Volyansky, A. Y., Davydova, T. V., Kuchma, M. V., Yudin, I. P., & I.Yu., K. (2020) · eNTUKhPIIR Repository (Kharkiv Polytechnic Institute) · doi:10.5281/zenodo.4382121 · Cited by 1
[Epidemiological features and mechanism of coronavirus disease 2019 in children].
Deng, Q., Liang, P., & Liu, H. (2021) · PubMed Central · doi:10.7499/j.issn.1008-8830.2012021 · Cited by 1
Henningsen, M. J., Khatam‐Lashgari, A., Olsen, K. B., Jacobsen, C., Brøchner, C. B., & Banner, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049083 · Cited by 1
Primer on the Pathogenesis of Severe COVID-19: Part Two
Walsh, T. J. (2020) · European Medical Journal · doi:10.33590/emj/20-00159 · Cited by 1
Deb, S., Mondal, R., Lahiri, D., Ganguly, U., & Shome, G. (2022) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20221501 · Cited by 1
Indoxyl Sulfate Alters the Humoral Response of the ChAdOx1 COVID-19 Vaccine in Hemodialysis Patients
Hou, Y., Wu, C., Lu, K., & Kuo, K. (2022) · Vaccines · doi:10.3390/vaccines10091378 · Cited by 1
Identification of Key Genes and Pathways in SARS-CoV-2 Infection using Bioinformatics AnalysisPreprint
Wang, Z., Jiang, C., Zhang, X., Zhang, Y., Ren, Y., & Gao, X. (2020) · Research Square · doi:10.21203/rs.3.rs-72821/v1 · Cited by 1
COVID-19 and Kidney Injury: Could Renin-Angiotensin Components Crosstalk with Immune Responses?Preprint
Nsengimana, B., Jin, Y., Jia, Y., Wei, W., & Ji, S. (2021) · Preprints.org · doi:10.20944/preprints202107.0642.v1 · Cited by 1
Lobentanzer, S. (2020) · doi:10.31219/osf.io/3gwmp · Cited by 1
Vaccination: tipping the balance from pathogen to host.
Ariaans, M. P. (2008) · Utrecht University Repository (Utrecht University)
Tonietti, P. D. O. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2013.tde-09122013-112652
Benefits of random-priming: Exhaustive survey of a cDNA library from lung tissue of a SARS patient
Wu, H., Wang, J., Deng, R., Xing, K., Xiong, Y., Huang, J., He, X., & Wang, X. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22012
Cell signalling and feline immunodeficiency virus growth and latency
Chan, C. N. (2013) · Enlighten: Theses (The University of Glasgow)
InfectionsMice from Lethal Respiratory Virus Intranasal Treatment with Poly(I·C) Protects
Perlman, S. M., Fleming, E., Lane, T. E., McCray, P. B., Zhao, J., Wohlford-Lenane, C., & Zhao, J. (2012)
Totura, A. L. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/vkmg-md36
NK Cells and Cytokines in Health and Disease
Romee, R., & Miller, J. S. (2011) · Science Publishers eBooks · doi:10.1201/b11037-15
Bolles, M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/yqyj-ht59
Ciapponi, A. (2020) · Evidencia actualizacion en la práctica ambulatoria · doi:10.51987/evidencia.v23i3.6867
Liberty and Pandemics: A Libertarian Approach to the Global COVID-19 SituationPreprint
Asudemade, H. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3630126
Conducting Elections During a PandemicPreprint
Becker, D. G. (2020) · SSRN Electronic Journal
Immune Responses to Corona Family Viruses and Vaccine Strategies
Andalib, A. (2020) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22122/jims.v38i579.12899
Covid-19: features of the pathogenesis of the disease and targets for immunotherapeutic effects
Klimov, N. A., & Simbirtsev, A. S. (2020) · Medical academic journal · doi:10.17816/maj48959
The War Against SARS-CoV-2: The Immune Giant Collapsing Under Its Own Rampaging Cytokine Storm
Sofra, X. (2021) · Journal of Endocrinology and Metabolism Research · doi:10.37191/mapsci-2582-7960-2(1)-013
Neuromuscular Problems in the Patients With COVID-19: A Review Study
Motaqi, M., Hatef, B., Ashtiani, A. A., & Ghanjal, A. (2021) · Physical Treatments - Specific Physical Therapy · doi:10.32598/ptj.11.2.73.1
Comparing Expression of OAS-RNaseL Pathway-Related Genes in SARS-CoV-2 and Similar VirusesPreprint
Chakravarty, N., Edillor, P. A., Huang, A. P., Torres, G. A., Usmani, M. T., & Kadandale, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.29.442063
FMT: A Potential Therapeutic and Rehabilitative Intervention for COVID-19
Liu, F., Ye, S., Wang, J., Xin, Z., Liu, Y., Li, Y., & Deng, Z. (2020) · Journal of Clinical and Nursing Research · doi:10.26689/jcnr.v4i6.1616
Lisianyi, M. I. (2021) · Immunology and Allergy Science and Practice · doi:10.37321/immunology.2021.3-02
Farzanegan, R., Llamazares, M. A. J., pez, A. N. L., Carrascosa, J. V. C., Fabra, M. J. B., Górriz, M. C. T., Aznar, R. C., Cuartero, J. B., Royo, M. M., & Enrique, E. (2020) · doi:10.22541/au.159646129.92125472
Aamir, M., Ahmad, W., Ahmad, B. I., Khan, A., Fawad, M. U., & Abdullah, M. A. K. (2021) · Gomal Journal of Medical Sciences · doi:10.46903/gjms/19.03.1029
Immunopathogenecity in COVID-19
Bashir, S., & Rashid, A. (2022) · Southeast Asian Journal of Case Report and Review · doi:10.18231/j.sajcrr.2021.002
Cassetta, L., Poli, G., & Alfano, M. (2011) · Science Publishers eBooks · doi:10.1201/b11037-14
Clinical Investigation of Lymphocyte DNA Damage in COVID-19 PatientsPreprint
Doğan, H., Kara, A., Çankaya, E., Balkan, E., Gürbüz, M. A., Kızılkaya, M., & Aykaç, M. (2022) · Research Square · doi:10.21203/rs.3.rs-2095176/v1
Inmunodeficiencias en contexto de infección por SARS-CoV-2
Nicolás Faúndes, G., Genskowsky, K., V, & Valeria Palma, P. (2021) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2021.69657
A Systematic Review of COVID-19 Impact on Cardiovascular Diseases
Khan, M. Z., Badruddeen, B., Khushtar, M., Akhtar, J., Khan, M. I., Ahmad, M., & Chand, I. (2023) · Coronaviruses · doi:10.2174/2666796704666230608121558
Paridiprubart inhibits TLR4-dependant NF-κB activation by multiple pathogensPreprint
Malty, R. H., Hilbe, R., Ahn, S., Kesselman, L., Lam, J., Kasawara, K. T., Costa, L. C., Rajakulendran, N., Gordon, B., Brooks, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.27.545921
Host immune responses in COVID-19
Bandopadhyay, P., & Ganguly, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18769-8.00009-x
การศกษาระดบแอนตบอดลบลางฤทธในผปวยโควด-๑๙ ทยนยนการตดเชอดวยปฏกรยาลกโซพอลเมอเรส แยกตามความรนแรงของโรค
ศิระวัฒนชัย, ฐ., & พุทธเจริญ, โ. (2021) · doi:10.58837/chula.the.2021.1137
Sotoudeheian, M., Azarbad, R., Mirahmadi, S., Pirhayati, M., Moradi, M., & Pazoki–Toroudi, H. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010324744240916110446
Bermejo-Martin, J. F., González‐Rivera, M., Almansa, R., Micheloud, D., Tedim, A. P., Domínguez‐Gil, M., Resino, S., Martín-Fernández, M., Ryan, P., Pérez-García, F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13466767
Self-citationBermejo-Martin, J. F., González‐Rivera, M., Almansa, R., Micheloud, D., Tedim, A. P., Domínguez‐Gil, M., Resino, S., Martín-Fernández, M., Ryan, P., Pérez‐García, F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13466771
Self-citationBermejo-Martin, J. F., González-Rivera, M., Almansa, R., Micheloud, D., Tedim, A. P., Domínguez‐Gil, M., Resino, S., Martín-Fernández, M., Ryan, P., Pérez‐García, F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13466761
Self-citationBermejo-Martin, J. F., González-Rivera, M., Almansa, R., Micheloud, D., Tedim, A. P., Domínguez‐Gil, M., Resino, S., Martín-Fernández, M., Ryan, P., Pérez-García, F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13466777
Self-citationBermejo-Martin, J. F., González‐Rivera, M., Almansa, R., Micheloud, D., Tedim, A. P., Domínguez‐Gil, M., Resino, S., Martín-Fernández, M., Ryan, P., Pérez‐García, F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13466775
Self-citationKulyova, A. A., Kulyova, S. A., Хабарова, Р. И., Senchurov, E. M., Михайлова, Е. А., Borokshinova, K. M., Ignatova, V. S., Prosekina, E. A., & Вершинина, Т. Л. (2025) · Podderživaûŝaâ terapiâ v onkologii. · doi:10.17650/3034-2473-2025-2-3-76-84
Respiratory viral infections and cold
Григорьевна, П. А., Perelman, J. M., & Колосов, В. П. (2026) · Bulletin physiology and pathology of respiration · doi:10.36604/1998-5029-2026-100-156-165
Interferon‐Mediated Regulation of Memory B Cell Identity and Function
Kirn, A., & Good‐Jacobson, K. L. (2026) · Immunological Reviews · doi:10.1111/imr.70161 · Cited by 1
Host Factor Experiment (DiegoM_AUM_01_Mouse_SARS_Expression)
J. Craig Venter Institute, & University of Chicago (2015) · Virus Pathogen Resource · doi:10.35083/36nd-sx41
BindingDB Entry 50016597: Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
BindingDB (2023) · UC San Diego · doi:10.7270/q2rf601n
Host Factor Experiment (SM001-R)
J. Craig Venter Institute, & University of Chicago (2011) · Virus Pathogen Resource · doi:10.35083/synf-z480
Host Factor Experiment (EjuanesL_AUM_01_VE6_MA104_Expression)
J. Craig Venter Institute, & University of Chicago (2012) · Virus Pathogen Resource · doi:10.35083/zfdd-cq08
Longitudinal Analyses Reveal Immunological Misfiring in Severe COVID-19 (Companion study to SDY1648)
Grubnaugh, N. D., Ko, A., Omer, S. B., & Iwasaki, A. (2020) · ImmPort · doi:10.21430/m3byphcd6f
Metadata
- Authors
- Cameron, M. J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J. F., Cameron, C. M., Muller, M. P., Gold, W. L., Richardson, S. E., Poutanen, S. M., Willey, B. M., DeVries, M. E., Fang, Y., Seneviratne, C., Bosinger, S. E., Persad, D., Wilkinson, P., Greller, L. D., Somogyi, R., Humar, A., Keshavjee, S., Louie, M., Loeb, M. B., Brunton, J., McGeer, A. J., the Canadian SARS Research Network, & Kelvin, D. J.
- Affiliations
- University Health Network (CA)
- University of Valladolid, Valladolid, Spain
- Mount Sinai Hospital (CA)
- University of Toronto (CA)
- University Health Network, Toronto, Ontario, Canada
- Centre Hospitalier de l’Université de Montréal (CA)
- Biosystemix, Sydenham, Ontario, Canada
- Provincial Laboratory of Public Health (CA)
- McMaster University (CA)
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-08-15
- Volume
- 81
- Issue
- 16
- Pages
- 8692-8706
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC1951379
- OpenAlex
- W2049902839
- Cited by
- 386
- References
- 59
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 14 · 2022: 31 · 2021: 71 · 2020: 121 · 2019: 5 · 2018: 1 · 2017: 8 · 2016: 7 · 2015: 10 · 2014: 11 · 2013: 10 · 2012: 10
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Genome Canada
- Ontario Genomics
- Ontario Genomics Institute
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS, interferon, type I interferon, interferon-stimulated genes, interferon-alpha, interferon-gamma, chemokines, innate immunity, adaptive immunity, immunopathology, SARS-CoV, spike antibodies, immunoglobulin genes, gene expression signatures, cytokine storm, H5N1 avian influenza, viral pathogenesis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antibodies, Viral, Antibody Formation, Female, Humans, Immunity, Innate, Interferons, Male, Middle Aged, Gene Expression, Cytokines, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Genomics, Proteomics, Severe Acute Respiratory Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review